Orlando, FL -- (SBWIRE) -- 10/29/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On GTx, Inc.(NASDAQ:GTXI), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP).
GTx, Inc.(NASDAQ:GTXI) shares increased 0.29% to $1.75 in yesterday’s session. The company on Oct. 24 announced that a poster presentation, entitled Results from two Phase 3 randomized trials of enobosarm, a selective androgen receptor modulator (SARM), for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer (NSCLC) receiving chemotherapy, will be given by Jeffrey Crawford, M.D., Chief, Division of Medical Oncology at Duke University School of Medicine, and principal investigator for the POWER1 (platinum plus taxane) and POWER2 (platinum plus non-taxane) trials, which were chemotherapy add-on placebo controlled studies.
Are investors worried about the recent updates with GTXI? Find out with a free trend analysis HERE
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) shares decreased 0.55% to $3.60. The company on Oct. 24 announced the pricing of its previously announced public offering of 14,300,000 shares of its common stock at a public offering price of $3.50 per share. All of the shares in the offering are being sold by ZIOPHARM. The offering is expected to close on October 29, 2013, subject to customary closing conditions. The company intends to use the net proceeds from the public offering for the overall development of its drug candidates, including its synthetic biology candidates and small molecule candidates, and for general corporate and working capital purposes.
Is ZIOP going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)